Advertisement

Topics

Imprimis Pharmaceuticals Completes Name Change to Harrow Health

11:47 EST 31 Dec 2018 | Investing News Network

Harrow Health (NASDAQ:IMMY) announced it has formally changed its name and that it will trade as “HROW” on The NASDAQ Capital Markets beginning at market open January 2, 2019. As quoted in the press release: Mark L. Baum, CEO of Harrow Health, stated, “Our new name reflects our business model of creating, investing in, operating … Continued

The post Imprimis Pharmaceuticals Completes Name Change to Harrow Health appeared first on Investing News Network.

Original Article: Imprimis Pharmaceuticals Completes Name Change to Harrow Health

NEXT ARTICLE

More From BioPortfolio on "Imprimis Pharmaceuticals Completes Name Change to Harrow Health"

Advertisement
Quick Search
Advertisement
Advertisement